Karuna Therapeutics, Inc.

VANGUARD GROUP INC

Report date

12/31/2023

Quarter

2023 Q4

Filed

3/11/2024

Shares

3,224,786

Value ($000)

1,020,677

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	3/11/2024	1,020,677	0.0%	3,224,786	12/31/2023
2023 Q3	12/18/2023	541,694	0.0%	3,203,585	9/30/2023
2023 Q2	8/14/2023	671,779	0.0%	3,097,899	6/30/2023
2023 Q1	7/14/2023	548,470	0.0%	3,019,546	3/31/2023
2022 Q4	2/10/2023	541,071	0.0%	2,753,543	12/31/2022
2022 Q3	11/14/2022	589,672	0.0%	2,621,585	9/30/2022
2022 Q2	8/12/2022	274,870	0.0%	2,172,714	6/30/2022
2022 Q1	5/13/2022	268,940	0.0%	2,121,152	3/31/2022
2021 Q4	2/14/2022	273,048	0.0%	2,084,336	12/31/2021
2021 Q3	11/12/2021	252,659	0.0%	2,065,391	9/30/2021
2021 Q2	8/13/2021	229,775	0.0%	2,015,750	6/30/2021
2021 Q1	5/14/2021	229,543	0.0%	1,909,203	3/31/2021
2020 Q4	2/12/2021	123,798	0.0%	1,218,601	12/31/2020
2020 Q3	11/16/2020	92,225	0.0%	1,192,754	9/30/2020
2020 Q2	8/14/2020	121,553	0.0%	1,090,552	6/30/2020
2020 Q1	5/15/2020	36,251	0.0%	503,467	3/31/2020
2019 Q4	2/14/2020	32,393	0.0%	429,954	12/31/2019